These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3292598)

  • 21. A randomized, double-blind study of valsartan versus metoprolol on arterial distensibility and endothelial function in essential hypertension.
    Kosch M; Levers A; Lang D; Bartels V; Rahn KH; Pavenstädt H; Hausberg M
    Nephrol Dial Transplant; 2008 Jul; 23(7):2280-5. PubMed ID: 18194979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of oral MK 421 and propranolol in mild to moderate essential hypertension and their effects on arterial and venous vessels of the forearm.
    Simon AC; Levenson JA; Bouthier JD; Benetos A; Achimastos A; Fouchard M; Maarek BC; Safar ME
    Am J Cardiol; 1984 Mar; 53(6):781-5. PubMed ID: 6322565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic and hemodynamic effects of antihypertensive treatment with ketanserin.
    Levinson PD; Zimlichman R; Goldstein DS; Brewer HB; Keiser HR
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):245S-248S. PubMed ID: 3415801
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hemodynamic effects of carvedilol after acute oral administration in hypertensive and normal subjects.
    Cournot A; Lim C; Duchier J; Safar M
    J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S35-9. PubMed ID: 1378147
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term safety and efficacy of ketanserin in essential hypertension: ketanserin versus or in combination with metoprolol.
    Mauersberger H
    J Hypertens Suppl; 1986 Apr; 4(1):S73-5. PubMed ID: 2939217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute haemodynamic effect of metoprolol in essential hypertension.
    Pechán J; Mikulecký M; Srbecký M
    Cor Vasa; 1988; 30(1):51-9. PubMed ID: 3132353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ketanserin on blood pressure, peripheral circulation and haemocoagulative parameters in essential hypertensives with or without arteriosclerosis obliterans of the lower limbs.
    Novo S; Alaimo G; Abrignani MG; Giordano U; Avellone G; Pinto A; Adamo L; Cutietta A; Indovina A; Strano A
    Int J Clin Pharmacol Res; 1986; 6(3):199-211. PubMed ID: 2943685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of celiprolol on large and small arteries of the forearm circulation in hypertensive patients.
    Roman O; Meza N; Klenner C
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):745-9. PubMed ID: 2150174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Haemodynamic effects of metoprolol and pindolol: a comparison in hypertensive patients.
    Svensson A; Gudbrandsson T; Sivertsson R; Hansson L
    Br J Clin Pharmacol; 1982; 13(Suppl 2):259S-267S. PubMed ID: 7104149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular profile and hypotensive mechanism of ketanserin in the rabbit.
    Bolt GR; Saxena PR
    Hypertension; 1985; 7(4):499-506. PubMed ID: 2861161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal and limb vasodilatation during acute beta-adrenoceptor blockade with indenolol.
    Poggesi L; Bisi G; La Cava G; Sciagra R; Del Rosso A; Masotti G
    J Clin Pharmacol; 1995 Feb; 35(2):176-81. PubMed ID: 7751429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The haemodynamic effects of ketanserin versus dihydralazine in severe early-onset hypertension in pregnancy.
    Bolte AC; van Eyck J; Strack van Schijndel RJ; van Geijn HP; Dekker GA
    Br J Obstet Gynaecol; 1998 Jul; 105(7):723-31. PubMed ID: 9692412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mode of action of beta-adrenoceptor blocking agents in hypertension. A comparison between metoprolol and pindolol with special reference to peripheral vascular effects.
    Svensson A; Gudbrandsson T; Sivertsson R; Hansson L
    Acta Med Scand Suppl; 1982; 665():103-8. PubMed ID: 6760678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative study of ketanserin and metoprolol in essential hypertension.
    Kane JA; Tooley M; Sibbald B; Gould SE
    J Hypertens Suppl; 1986 Apr; 4(1):S63-5. PubMed ID: 2939215
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic effects of metoprolol and methyldopa on calf blood flow in intermittent claudication.
    Lepäntalo M
    Br J Clin Pharmacol; 1984 Jul; 18(1):90-3. PubMed ID: 6378235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of ketanserin on blood pressure and biochemical parameters in treated patients with essential hypertension.
    Wing LM; Chalmers JP; West MJ; Bune AJ; Ayres B; Graham JR
    Clin Exp Hypertens A; 1984; 6(6):1107-17. PubMed ID: 6146414
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential effects of nebivolol and metoprolol on central aortic pressure and left ventricular wall thickness.
    Kampus P; Serg M; Kals J; Zagura M; Muda P; Karu K; Zilmer M; Eha J
    Hypertension; 2011 Jun; 57(6):1122-8. PubMed ID: 21536983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ketanserin: systemic and regional hemodynamic characterization of its serotonergic and alpha-adrenergic receptor blocking effects in the pithed SHR.
    Scalbert E; Richer C; Giudicelli JF
    J Cardiovasc Pharmacol; 1989 Jan; 13(1):94-104. PubMed ID: 2468942
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of ketanserin on blood pressure and biochemical parameters in patients with essential hypertension.
    Wing LM; Chalmers JP; West MJ; Bune AJ; Ayres B; Graham JR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S164-7. PubMed ID: 2412043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Local hemodynamic effects of serotonin and ketanserin in healthy subjects: studies in the forearm.
    Blauw GJ; van Brummelen P; Bruning T; van Zwieten PA
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S41-3. PubMed ID: 2459513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.